VAREX IMAGING (VREX) reported $212.9 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 3.3%. EPS of $0.26 for the same period compares to $0.16 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $206.83 million, representing a surprise of +2.93%. The company delivered an EPS surprise of +85.71%, with the consensus EPS estimate being $0.14.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...

VAREX IMAGING (VREX) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 85.71%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings of $0.07, delivering a surprise of 75%.Over the last four quarters, the company has s ...

Varex Imaging (VREX) Q2 2025 Earnings Call May 08, 2025 05:00 PM ET Speaker0 and welcome to the Verix Q2 Fiscal Year twenty twenty five Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce you to your host Chris Balfour, Director of Investor Relations. Thank you, Chris. You may begin. Speaker1 Good afternoon and welcome to Verix Imaging Corporatio ...

Making the Invisible Visible Q2 FY25 Earnings Presentation May 8, 2025 5/8/2025 1 Forward Looking Statements This supplement contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning financial results; earnings guidance; tariffs and trade wars and their impact on our customers; industry or business outlook, including for our business in China; product demand; payoff of our convertible debt; expected future financial results or per ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ____________________________________________________________ For the quarterly period ended April 4, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 ____________ ...

Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2025 SALT LAKE CITY, May 8, 2025 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2025. 2QFY25 Summary Balance Sheet & Cash Flow Cash flow from operations was $17 million in the second quarter of fiscal year 2025. Cash, cash equivalents, and marketable securities at the end of the second quarter of fiscal year 2025 was $226 million, excluding the $125 ...

VAREX IMAGING (VREX) shares soared 16.5% in the last trading session to close at $8.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 41.8% loss over the past four weeks.The upside can be attributed to relief-rally across global markets following the announcement of a 90-day pause on tariff hike by the United States.This company is expected to post quarterly earnings of $0.14 per share in its upcoming report, which represents a ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.On top of the ...

Financial Data and Key Metrics Changes - Revenue increased by 5% year over year, with medical segment revenue up 3% and industrial segment revenue up 10% [11][30] - Non-GAAP gross margin was 35%, up from 31% in the same quarter last year [11][34] - Adjusted EBITDA for the quarter was $24 million, compared to $19 million in the previous year [11][37] - Cash from operations was $10 million, with total cash, cash equivalents, and marketable securities at $219 million, up $24 million year over year [12][40] Business Line Data and Key Metrics Changes - Medical segment revenue was $145 million, constituting 72% of total revenue, while industrial segment revenue was $55 million, making up 28% [30] - In the medical segment, sales of CT tubes drove growth, while radiography, oncology, and dental modalities were below sales trends [13][15] - Industrial segment saw strong demand in security screening, particularly for baggage inspection and cargo screening [15][19] Market Data and Key Metrics Changes - Americas revenue increased by 3%, EMEA decreased by 9%, and APAC increased by 22%, driven by improved sales in China [31] - Sales in China accounted for 18% of total sales, increasing 7% year over year and 12% sequentially [31][68] Company Strategy and Development Direction - The company is optimistic about long-term growth in imaging in China and plans to begin production of radiographic components in India [22][23] - The cargo and security scanning systems are viewed as a significant long-term growth opportunity, with an estimated annual serviceable opportunity of over $1 billion [20][21] - The company is focusing on expanding its offerings in cargo and security inspection to enhance security and improve trade compliance [16][20] Management's Comments on Operating Environment and Future Outlook - Management noted solid demand trends but highlighted unscheduled absences in US facilities as a challenge in fulfilling demand [9][75] - The company is monitoring tariff announcements closely but does not expect significant direct impacts on its business at this time [24][109] - Management expressed cautious optimism regarding the recovery in China, emphasizing that the long-term outlook remains positive despite current uncertainties [48][112] Other Important Information - The company ended the quarter with $571 million in gross debt, with a net debt leverage ratio of approximately 2.4 times adjusted EBITDA [41][42] - R&D spending was $23 million, representing 12% of revenues, with SG&A expenses at $31 million [35][36] Q&A Session Summary Question: Can you provide more details on the performance in China? - Management noted an uptick in sales in China but does not expect a meaningful improvement in demand this year [47][48] Question: What is the margin profile for the cargo and vehicle inspection systems? - The margin profile for hardware is expected to be lower initially, but service revenue margins are anticipated to improve over time [50][51] Question: What percentage of the industrial segment does the cargo inspection business comprise? - Cargo inspection is a significant part of the security inspection market, which constitutes about 40% of industrial sales [61] Question: How is the destocking phenomenon affecting orders? - Management indicated that destocking is largely behind them, leading to an uptick in order rates [81][127] Question: What is the status of the new plant in India? - The plant is on track to go online by the end of the fiscal year, focusing on detectors initially [118][121] Question: How will the new administration's focus on border security impact sales? - Management believes that increased focus on security globally will raise activity levels for cargo inspection tenders [130]

VAREX IMAGING (VREX) reported $199.8 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 5.2%. EPS of $0.07 for the same period compares to $0.06 a year ago.The reported revenue represents a surprise of -2.32% over the Zacks Consensus Estimate of $204.55 million. With the consensus EPS estimate being $0.04, the EPS surprise was +75.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to det ...